⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL628337 | 0.96 | — | — | |
| SCHEMBL29259898 | 0.92 | — | — | |
| Glycerin SCHEMBL22265189 | 0.82 | THRB (0.65) | — | |
| Urea SCHEMBL27715198 | 0.79 | THRB (0.38) | — | |
| Acetic Acid SCHEMBL21295164 | 0.77 | FFAR3 (0.41) | — | |
| SCHEMBL28957646 | 0.74 | THRB (0.56) | — | |
| SCHEMBL599332 | 0.72 | — | — | |
| SCHEMBL1448305 | 0.71 | — | — | |
| SCHEMBL6594166 | 0.70 | THRB (0.36) | — | |
| SCHEMBL6548251 | 0.70 | THRB (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1016711-B1 | Process for inactivating enveloped viruses in a viral composition containing adenoviruses | TRANSGENE SA (FR) | 2004-10-27 | — | — | EP | disclosed |
| US-6365330-B1 | AMINOALCOHOL AND N-ALKOXYLATED MONO- OR POLYFUNCTIONAL AMINES; AMPHOTERIC AND ANIONIC SURFACTANTS; GLUCONIC ACID COMPLEXING AGENT; NO SOLID OR GEL-LIKE PRECIPITATES FORM DURING USE; | AGFA-GEVAERT AG (DE) | 2002-04-02 | — | — | US | disclosed |
| EP-1155120-A1 | METHOD FOR OBTAINING A PURIFIED VIRAL PREPARATION | TRANSGENE S.A. (FR) | 2001-11-21 | — | — | EP | disclosed |
| WO-2000050573-A1 | METHOD FOR OBTAINING A PURIFIED VIRAL PREPARATION | TRANSGENE S.A. (FR) | 2000-08-31 | — | — | WO | disclosed |
| EP-1016711-A1 | Process for inactivating enveloped viruses in a viral preparation containing non-enveloped viruses | TRANSGENE S.A. (FR) | 2000-07-05 | — | — | EP | disclosed |